Solstein Capital’s Arcosa ACA Stock Holding History

Solstein Capital’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,245	Closed	-$419K	–	416
2021 Q3	$419K	Buy	+30,245	New	+$1.57M	0.24%	93

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Solstein Capital's ACA Position: Q4 2021 in Review

Solstein Capital sold out of Arcosa (ACA) in Q4 2021, closing a stake of 30,245 shares — an estimated $419K sold.

Solstein Capital first reported a position in ACA in Q3 2021 and held it in 1 quarter. The position peaked at $419K in Q3 2021. 249 funds tracked by Wall St. Rank hold ACA as of Q4 2021.

Solstein Capital reported no remaining Arcosa position as of Q4 2021 after selling out during the quarter.
Solstein Capital sold 30,245 Arcosa shares in Q4 2021, an estimated $419K.
Solstein Capital first reported a position in Arcosa in Q3 2021 and held it in 1 quarter.
Solstein Capital's Arcosa position peaked at $419K in Q3 2021.
249 funds tracked by Wall St. Rank held Arcosa as of Q4 2021.

Based on Solstein Capital's 13F filing for Q4 2021, filed 27 Jan 2022.